STOCK IN FOCUS: Piramal Pharma

Profit down due to tax adjustments. 

Profit Before Tax (PBT) up 246% YoY at ₹66.8 Cr, down 44% QoQ.

#PiramalPharma #ProfitBeforeTax #TaxAdjustments #StockMarket #FinancialResults
#PiramalPharma #ProfitBeforeTax #TaxAdjustments #StockMarket #FinancialResults